¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Multiple system failure"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • sound conduction system
    ¼Ò¸®Àü´Þ°èÅë, ÀüÀ½°è
  • static system
    Á¤Áö°è
  • stereotactic system
    Á¤À§°íÁ¤±â
  • subcortical descending system
    °ÑÁú¹ØÇÏÇà°è, °ÑÁú¹Ø³»¸²°èÅë
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë
  • to and fro absorbent system
    ¿Õº¹Èí¼ö½Äȸ·Î
  • transdermal drug delivery system
    °æÇǾ๰Àü´Þü°è
  • urinary system
    ºñ´¢°èÅë
  • urogenital system
    ºñ´¢»ý½Ä°èÅë
  • value system
    °¡Ä¡Ã¼°è
  • vascular system
    Ç÷°ü°èÅë
  • vegetative nervous system
    (¢¡autonomic nervous system) ÀÚÀ²½Å°æ°èÅë
  • workload recording system
    ÀÛ¾÷ºÎÇϱâ·Ïü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(ÒýÛ¡àõÌ¿ï½àõË£ßÒàÍðþ).
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(¡­Ì¿ï½àõË£ßÒàÍðþ)
  • multiple nodular goiter
    ´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(´Ù¹ß¼º°áÀý¼º°©»ó¼±Á¾).
  • multiple organ dysfunction
  • multiple overlapping thin slab acquisition (MOTSA)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • multiple paramyoclonus
    ´Ù¹ß¼º ±Ù°£´ë°æ·Ã(ÒýÛ¡àõÐÉÊàÓÛÌâÕý).
  • multiple personality
  • multiple personalty disorder
  • multiple petechia
    ´Ù¹ß¼º Á¡»óÃâÇ÷(¡­ïÇßÒõóúì)
  • multiple placenta
    ¹µÅ¹Ý
  • multiple polyp
    ´Ù¹ß¼º(ÒýÛ¡àõ) Æú¸³.
  • multiple polyp
    ´Ù¹ß¼º Æú¸³
  • multiple polyp
    ´Ù¹ß¼º(´Ù¹ß¼º) Æú¸³.
  • multiple pressure method
    ´Ù¾Ð¹ý(ÒýäâÛö).
  • multiple progressive angioma
    ´Ù¹ß¼º ÁøÇ༺ Ç÷°üÁ¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
CRVF congestive right ventricular failure
CVF cardiovascular failure; central visual field; cervicovaginal fluid; cobra venom factor
ESLF end-stage liver failure
ESRF end-stage renal failure
FHF fetal heart frequency; fulminant hepatic failure
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
MEN I Multiple Endocrine Neoplasia
MEN 1 Multiple Endocrine Neoplasia Type 1
MEN2a Multiple Endocrine Neoplasia Type 2a
MEN-I Multiple Endocrine Neoplasia Type I
MEN 2B Multiple Endocrine Neoplasia type 2B
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • shift system
    ±³´ëÁ¦ ±Ù¹«
    8½Ã°£ ÀÌ»óÀÇ ³ëµ¿À» ÇÊ¿ä·Î ÇÏ´Â Á÷Àå¿¡¼­ Á¶·Î ³ª´©¾î ÀÏÇÏ´Â Á¦µµ.
  • sodium transport system
    ³ªÆ®·ý ¿î¹Ý°è
  • stomatognathic system
    ±¸°­¾Ç°è, ±¸°­ ÇϾǰè, ¾Ç±¸°­°è
    Ä¡¾Æ, ¾Ç°ñ, ÃøµÎÇϾǰüÀý, ÀúÀÛ±Ù »çÀÌÀÇ ±â´ÉÀû ¹× ÇØºÎÇÐÀû °ü°è.
  • superficial musculoaponeurotic system
    Ç¥Ãþ ±Ù°Ç¸· ü°è
  • supraopticohypophyseal system
    ½Ã°¢ ±³Â÷ À§³úÇÏ ¼öü°è, ½Ã°¢·ÎÀ§ ³úÇÏ ¼öü·Î
  • sympathetic nerve system
    ±³°¨ ½Å°æ°è
  • sympathetic nervous system activity
    ±³°¨½Å°æ°è Ȱ¼º
  • sympatheticoadrenomedullary system
    ±³°¨½Å°æ ºÎ½Å ¼ÓÁú°è
  • system
    °èÅë, ü°è, ±â°ü°è, °è, Àü½Å
  • system lupus erythematosus
    Àü½Å¼º È«¹Ý¼º ³¶Ã¢
  • TNM-system
    TNM °è
  • to and fro absorbent system
    ¿Õº¹ Èí¼ö¹ý
  • trigonal system
    »ï°¢Çü°è
  • vegatative nervous system
    ½Ä¹°¼º ½Å°æ°è
  • visceral sensory system
    ³»Àå °¨°¢°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
circulatory system The circulatory system is a composed of the heart, arteries, capillaries and veins. It serves to transport blood low in oxygen from the body to the lungs and heart (veins) and oxygenated blood from the lungs and heart throughout the body (arteries). (see heart, blood).
(12 Dec 1998)
phosphoenolpyruvate sugar phosphotransferase system <enzyme> The bacterial sugar phosphotransferase system (pts) that catalyses the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates (the pts sugars) concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, enzyme I and hpr and a pair of sugar-specific proteins designated as the enzyme II complex. The pts has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the pts as well as the regulation of the activity of adenylate cyclase.
Registry number: EC 2.7.1.-
(12 Dec 1998)
closed system <biology, ecology> A chemical or biological system that exchanges no matter or energy with the ouside environment.
(12 Mar 1998)
mnss blood-group system A system of universal human blood group isoantigens with many associated subgroups. The m and n traits are codominant and the s and s traits are probably very closely linked alleles, including the u antigen. This system is most frequently used in paternity studies.
(12 Dec 1998)
Pinel's system The abolition of forcible restraint in the treatment of the mental hospital patient.
(05 Mar 2000)
mononuclear phagocyte system A widely distributed collection of both free and fixed macrophages derived from bone marrow precursor cells by way of monocytes; their substantial phagocytic activity is mediated by immunoglobulin and the serum complement system. In both connective and lymphoid tissue, they may occur as free and fixed macrophages; in the sinusoids of the liver, as Kupffer cells; in the lung, as alveolar macrophages; and in the nervous system, as microglia.
Synonym: system of macrophages.
(05 Mar 2000)
colloid system A combination of the two phases, internal and external, of a colloid solution; the various system's are: gas + liquid (foam); gas + solid (meerschaum); liquid + gas (fog); solid + gas (smoke); solid + liquid (sol); liquid + solid (gel); liquid + liquid (emulsion); solid + solid (coloured glass).
(05 Mar 2000)
pituitary-adrenal system The interactions between the anterior pituitary and adrenal glands, in which corticotropin (acth) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary.
(12 Dec 1998)
combined system disease A subacute or chronic disorder of the spinal cord, such as that occurring in certain patients with vitamin B12 deficiency, characterised by a slight to moderate degree of gliosis in association with spongiform degeneration of the posterior and lateral columns.
Synonym: combined sclerosis, combined system disease, funicular myelitis, Putnam-Dana syndrome, vitamin B12 neuropathy.
(05 Mar 2000)
motor system disease <disease> Degenerative disease of unknown cause that affects predominantly motor neurons of spinal cord, cranial nerve nuclei and motor cortex. There is speculation that deficiency in ciliary neurotrophic factor may be involved.
(18 Nov 1997)
complement system A group of more than 20 serum proteins, some of which can be serially activated and participate in a cascade resulting in cell lysis.
(05 Mar 2000)
conducting system of heart The system of atypical cardiac muscle fibres comprising the sinoatrial node, internodal tracts, atrioventricular node and bundle, the bundle branches, and their terminal ramifications into the Purkinje network; sometimes also called cardionector.
(05 Mar 2000)
multienzyme system A group of related enzymes that operate in a particular metabolic pathway.
(09 Oct 1997)
muscular system All the muscles of the body collectively.
(05 Mar 2000)
musculoskeletal system All the muscles, bones, and cartilages of the body collectively.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á